Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jan-Feb;16(1):37-48.
doi: 10.1002/rmv.483.

Mechanisms of action of ribavirin against distinct viruses

Jason D Graci  1 , Craig E Cameron
Affiliations
Review

Mechanisms of action of ribavirin against distinct viruses

Jason D Graci et al. Rev Med Virol. 2006 Jan-Feb.

Abstract

The nucleoside analogue ribavirin has antiviral activity against many distinct viruses both in vitro and in vivo. Five distinct mechanisms have been proposed to explain the antiviral properties of ribavirin. These include both indirect mechanisms (inosine monophosphate dehydrogenase inhibition, immunomodulatory effects) and direct mechanisms (interference with RNA capping, polymerase inhibition, lethal mutagenesis). Recent concerns about bioterrorism have renewed interest in exploring the antiviral activity of ribavirin against unique viruses. In this paper, we review the proposed mechanisms of action with emphasis on recent discoveries, as well as the implications of ribavirin resistance. Evidence exists to support each of the five proposed mechanisms of action, and distinct virus/host combinations may preferentially favour one or more of these mechanisms during antiviral therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Witkowski JT, Robins RK, Sidwell RW, Simon LN. Design, synthesis, and broad spectrum antiviral activity of 1‐ ‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide and related nucleosides. J Med Chem 1972; 15(11): 1150–1154. - PubMed
    1. Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad‐spectrum antiviral activity of Virazole: 1‐beta‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide. Science 1972; 177(50): 705–706. - PubMed
    1. Prusiner P, Sundaralingam M. A new class of synthetic nucleoside analogues with broad‐spectrum antiviral properties. Nat New Biol 1973; 244(134): 116–118. - PubMed
    1. Cummings KJ, Lee SM, West ES et al Interferon and ribavirin vs interferon alone in the re‐treatment of chronic hepatitis C previously nonresponsive to interferon: a meta‐analysis of randomized trials. Jama 2001; 285(2): 193–199. - PubMed
    1. Davis GL, Esteban‐Mur R, Rustgi V, et al Interferon alfa‐2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339(21): 1493–1499. - PubMed

Publication types